ADVERTISEMENT

Novartis

Bausch + Lomb to buy Novartis eye drop for $1.75 bn

Acquisition of the drug, Xiidra, will mark the first big deal by CEO Brent Saunders since he returned to the company in March.

30 June 2023, 13:10 IST

Bausch + Lomb to buy Novartis eye drop for $1.75 billion

Bausch + Lomb to buy Novartis eye drop for $1.75 billion

Bausch + Lomb to buy Novartis eye drop for $1.75 bn

30 June 2023, 13:10 IST

India's cardiac sector in for major disruptions: Report

With the drug going off patent, many pharmaceutical companies have jumped on the chance to market generic versions of the drug

04 December 2022, 09:46 IST

India's cardiac sector in for major disruptions as top Novartis heart drug set to go off patent: Report

India's cardiac sector in for major disruptions as top Novartis heart drug set to go off patent: Report

India's cardiac sector in for major disruptions: Report

04 December 2022, 09:46 IST

First-ever licencing deal struck for cancer drug

Novartis president of global health and sustainability Lutz Hegemann said the company was proud to be pioneering this new licensing model with MPP

20 October 2022, 10:07 IST

First-ever licencing deal struck for cancer drug

First-ever licencing deal struck for cancer drug

First-ever licencing deal struck for cancer drug

20 October 2022, 10:07 IST

Novartis slashes 8,000 jobs worldwide

The company aims to simplify its structure, among other things gathering oncology and other pharmaceutical activities in a single division

29 June 2022, 09:10 IST

Novartis slashes 8,000 jobs worldwide

Novartis slashes 8,000 jobs worldwide

Novartis slashes 8,000 jobs worldwide

29 June 2022, 09:10 IST

Novartis sells voting stake sale to Roche for $20.7 bn

The deal extricates Roche from ownership ties to a major competitor with strategic vetoing power

04 November 2021, 14:16 IST

Novartis cuts uneasy 20-year ties to Roche with $20.7 bn voting stake sale

Novartis cuts uneasy 20-year ties to Roche with $20.7 bn voting stake sale

Novartis sells voting stake sale to Roche for $20.7 bn

04 November 2021, 14:16 IST

Novartis says may divest generic drugs unit Sandoz

Third-quarter operating profit, adjusted for special items, rose 10% to $4.47 billion, driven by higher sales of arthritis and psoriasis drug Cosentyx

26 October 2021, 10:40 IST

Novartis says may divest generic drugs unit Sandoz

Novartis says may divest generic drugs unit Sandoz

Novartis says may divest generic drugs unit Sandoz

26 October 2021, 10:40 IST

Novartis signs deal to produce Pfizer-BioNTech vaccine

The financial terms of the agreement were not disclosed

21 October 2021, 10:29 IST

Novartis signs new deal to help produce Pfizer-BioNTech vaccine

Novartis signs new deal to help produce Pfizer-BioNTech vaccine

Novartis signs deal to produce Pfizer-BioNTech vaccine

21 October 2021, 10:29 IST

'4 more Indian firms may soon start vaccine production'

Even 7 to 9 per cent of the doses that remain unutilised by private hospitals are being used by the government vaccination centres, he added

03 August 2021, 11:19 IST

4 more Indian pharmaceutical firms expected to start vaccine production by Oct-Nov, says Mansukh Mandaviya

4 more Indian pharmaceutical firms expected to start vaccine production by Oct-Nov, says Mansukh Mandaviya

'4 more Indian firms may soon start vaccine production'

03 August 2021, 11:19 IST

Novartis India Q4 net profit rises 43% to Rs 9.7 crore

Revenue from operations stood at Rs 99.29 crore as compared to Rs 93.7 crore in the year-ago quarter

17 June 2021, 15:07 IST

Novartis India Q4 net profit rises 43% to Rs 9.7 crore

Novartis India Q4 net profit rises 43% to Rs 9.7 crore

Novartis India Q4 net profit rises 43% to Rs 9.7 crore

17 June 2021, 15:07 IST

Masks, social distancing keep Novartis profits at bay

Novartis's Sandoz generics unit is also grappling with persistent price pressure from rivals

27 April 2021, 11:10 IST

Novartis sees drop in sales, profit as masks, social distancing keep flu at bay

Novartis sees drop in sales, profit as masks, social distancing keep flu at bay

Masks, social distancing keep Novartis profits at bay

27 April 2021, 11:10 IST